DIA402.27+1.25 0.31%
SPX5,528.75+3.54 0.06%
IXIC17,366.13-16.81 -0.10%

Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday

Benzinga·04/03/2025 13:56:55
Listen to the news

U.S. stocks were lower, with the Dow Jones index falling over 1,200 points on Thursday.

Shares of Lamb Weston Holdings, Inc. (NYSE:LW) rose sharply during Thursday's session after the company reported better-than-expected third-quarter financial results and issued FY25 sales guidance above estimates.

Lamb Weston reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of 87 cents per share. The company reported quarterly sales of $1.52 billion which beat the analyst consensus estimate of $1.49 billion.

Lamb Weston shares jumped 10% to $59.52 on Thursday.

Here are some other big stocks recording gains in today's session.

  • The Goodyear Tire & Rubber Company (NASDAQ:GT) shares jumped 12.5% to $10.25.
  • Northern Dynasty Minerals Ltd. (NYSE:NAK) gained 12% to $1.0250.
  • Skyline Builders Group Holding Limited (NASDAQ:SKBL) shares rose 7.1% to $11.10.
  • National Grid plc (NYSE:NGG) shares rose 6.5% to $70.08.
  • SBA Communications Corporation (NASDAQ:SBAC) shares gained 6.1% to $232.69.
  • Anbio Biotechnology (NASDAQ:NNNN) rose 5.6% to $7.39.
  • The Kroger Co. (NYSE:KR) climbed 4.7% to $70.44.
  • American Tower Corporation (NYSE:AMT) shares rose 4.4% to $227.53.
  • Valneva SE (NASDAQ:VALN) gained 4.2% to $7.29.
  • Fresenius Medical Care AG (NYSE:FMS) rose 4.2% to $25.76.
  • McKesson Corporation (NYSE:MCK) gained 4% to $721.00. McKesson, on Wednesday, completed acquisition of PRISM Vision Holdings, LLC.
  • Sanofi (NASDAQ:SNY) rose 3% to $55.59 as the FDA granted Orphan Drug Status to the company's Rilzabrutinib for two rare autoimmune diseases with high unmet needs.

Now Read This:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.